Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 353 | 0 | 400 | 734 | 0 |
| Gross Profit | 353 | N/A | 400 | 734 | N/A |
| Operating Expenses | 5 | 0 | 1,262 | 1,195 | 0 |
| Operating Income | -5 | N/A | -862 | -461 | N/A |
| Interest Expense | 868 | 0 | 711 | 531 | 0 |
| Other Income | 868 | 0 | 3 | 10 | -3 |
| Pre-tax Income | -5 | 0 | -1,570 | -982 | -3 |
| Income Tax | N/A | N/A | 2 | N/A | 0 |
| Net Income Continuous | -5 | N/A | -1,572 | -982 | N/A |
| Net Income | $-5 | $N/A | $-1,572 | $-982 | $N/A |
| EPS Basic Total Ops | 0.00 | N/A | -9.01 | -5.71 | 0.00 |
| EPS Basic Continuous Ops | -0.03 | N/A | -9.01 | -5.63 | N/A |
| EPS Diluted Total Ops | 0.00 | N/A | -9.01 | -5.71 | 0.00 |
| EPS Diluted Continuous Ops | -0.03 | N/A | -9.01 | -5.63 | N/A |
| EBITDA(a) | $-1,088 | $N/A | $-370 | $-177 | $N/A |